Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

BMC Cancer, 2026

Exploration of plasma proteomic landscapes using Olink Reveal technology to identify biomarkers for early-stage/localized gastric cancer

Ding S., Li X., Dong X. et al.

Animal Models and Experimental Medicine, 2026

Age‐associated immune dysregulation links to disease severity in macrolide‐resistant Mycoplasma pneumoniae pneumonia: Insights from a comparative juvenile–adult mouse model

Li X., Wang Y., Liu L. et al.

Neurocritical Care, 2026

Mendelian Randomization Analysis of the IL-1 Cytokine Family Proteins Identifies IL1RL1 as a Potential Causal Contributor to Traumatic Brain Injury Prognosis

Bhak Y., Helmy A., Needham E. et al.

International Journal of Women's Health, 2026

Causal Effects of Circulating Inflammatory Proteins on Postmenopausal Atrophic Vaginitis in European Populations: A Mendelian Randomization Study with Transcriptomic Validation

Hu X., Ruan S., Zhong T. et al.

Molecular Psychiatry, 2026

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics

Jones G., Gilbert J., Johnston J. et al.

Theranostics, 2026

Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer

Yang J., Li Q., Zhao P. et al.

BMC Cancer, 2026

Sleep patterns and breast cancer risk: a prospective cohort study integrating multi-omics and machine learning

Chang X., Zuo S., Wang Z. et al.

European Journal of Preventive Cardiology, 2026

Women with angina and no obstructive coronary artery disease: IL-6 identifies a cardiometabolic high-risk phenotype and predicts cardiovascular events

Haahr R., Rytoft L., Mygind N. et al.

Nature Medicine, 2026

Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS

Ran X., Wuu J., Qin Z. et al.

Cardiovascular Diabetology, 2026

Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort

Zhou J., Mychaleckyj J., Haddad F. et al.

Aging Cell, 2026

Construction and Validation of Plasma Protein‐Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles

Zhong Y., Xia M., Zhao X. et al.

Journal of Colloid and Interface Science, 2026

Introduction of optimized folate group modification on lipid-coated magnetic nanobeads enables targeting of folate receptor beta

Schaaf M., Offer S., Zhang H. et al.

npj Genomic Medicine, 2026

Circulating cell-free RNA signatures associate with plaque calcification in advanced carotid atherosclerosis

Wei J., Lan T., Zhu Y. et al.

Neurological Sciences, 2026

Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia

Yao Y., Zou Q., Chen K.

International Journal of Cardiology, 2026

Activation of the complement lectin pathway is associated with long-term cardiac dysfunction and incident heart failure in acute coronary syndrome patients

Zhong B., King B., Mares R. et al.

Communications Biology, 2026

BMI-driven multi-omics analysis profiles the molecular mechanism of psycho-metabolic nexus and contributes to risk stratification

Guo X., Feng Y., Huang P. et al.

Allergy, 2026

Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk

Fyhrquist N., Riskumäki M., Karisola P. et al.

Proteomes, 2026

Proteomic Mediators Linking Autoimmune Diseases to Major Adverse Cardiovascular Events: Insights from the UK Biobank

Huang J., Liu C., Sperling L. et al.

Nature Genetics, 2026

Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk

Pietzner M., Williamson A., Hunt K. et al.

Diabetes, Obesity and Metabolism, 2026

Large‐Scale Plasma Proteomics Enhances Prediction of Liver‐Related Events Among Individuals With Prediabetes and Type 2 Diabetes: A Prospective Cohort Study in the UK Biobank

Ye C., Zhang Z., Ding Y. et al.

4626 publications